Please enable JavaScript to continue using this application.

Compare $SHC vs $TXG | Chartloom

Compare

$SHC vs $TXG

Sotera Health Co · 10X Genomics Inc

SHC

Sotera Health Co

TXG

10X Genomics Inc

Compare $SHC vs $TXG

Comparing Sotera Health Co and 10X Genomics Inc

SHCSotera Health Co

TXG10X Genomics Inc

SHCSotera Health Co

Market cap

$5.15B

P/E (TTM)

31.83x

Forward P/E (NTM)

17.43x

Forward P/S (NTM)

3.98x

Rev growth (TTM)

8.1%

YTD performance

2.1%

52W performance

12.9%

FCF yield

2.2%

TXG10X Genomics Inc

Market cap

$10.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

15.72x

Rev growth (TTM)

-4.3%

YTD performance

385.3%

52W performance

568.2%

FCF yield

1.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SHC

TXG

Detailed metrics comparison

SHC

Sotera Health Co

TXG

10X Genomics Inc

Market Cap

SHC$5.15B

TXG$10.24B

Enterprise Value

SHC$7.03B

TXG$9.74B

Price

SHC$18.06

TXG$80.65

P/E Ratio

SHC31.83x

TXGN/A

P/S Ratio

SHC4.23x

TXG16.60x

EV/Sales

SHC5.78x

TXG15.78x

EV/EBITDA

SHC13.41x

TXG0.00x

P/B Ratio

SHC7.81x

TXG14.76x

P/FCF Ratio

SHC45.70x

TXG84.32x

EV/FCF

SHC62.36x

TXG80.18x

PEG Ratio

SHC3.19x

TXGN/A

Forward P/E (NTM)

SHC17.43x

TXGN/A

Forward P/S (NTM)

SHC3.98x

TXG15.72x

Revenue (TTM)

SHC$1.22B

TXG$617M

Revenue Growth (YoY)

SHC8.1%

TXG-4.3%

Forward Rev Growth

SHC6.0%

TXG9.4%

Gross Margin (TTM)

SHC55.0%

TXG69.6%

Operating Margin (TTM)

SHC32.6%

TXG0.0%

EBITDA Margin (TTM)

SHC43.1%

TXG-7.8%

Net Margin (TTM)

SHC13.4%

TXG-12.2%

FCF Margin (TTM)

SHC9.3%

TXG19.7%

Net Income (TTM)

SHC$163M

TXG$-75M

FCF (TTM)

SHC$113M

TXG$121M

EPS (TTM)

SHC$0.57

TXG-$0.58

ROE (TTM)

SHC26.8%

TXG-933.0%

ROA (TTM)

SHC5.0%

TXG-730.0%

ROIC (TTM)

SHC5.7%

TXG-933.0%

Cash

SHC$357M

TXG$503M

Debt

SHC$2.23B

TXG$0

Net Cash/Debt

SHC$-1.88B

TXG$503M

Current Ratio (TTM)

SHC2.80x

TXG5.69x

Quick Ratio (TTM)

SHC2.45x

TXG5.09x

Debt/Equity (TTM)

SHC3.36x

TXG0.00x

Debt/Assets (TTM)

SHC0.0%

TXG0.0%

Interest Coverage (TTM)

SHCN/A

TXGN/A

Net Debt/EBITDA (TTM)

SHC0.00x

TXG0.00x

Beta

SHC1.93

TXG2.01

52W Performance

SHC12.9%

TXG568.2%

YTD Performance

SHC2.1%

TXG385.3%

% from 52W High

SHC-9.0%

TXG-21.6%

% from 52W Low

SHC38.0%

TXG622.7%

Asset Turnover (TTM)

SHC0.37x

TXG0.60x

FCF Yield (TTM)

SHC2.2%

TXG1.2%

Earnings Yield (TTM)

SHC3.2%

TXG-0.7%

Dividend Yield (TTM)

SHCN/A

TXGN/A

Rule of 40

SHC17.4

TXG15.4

EV/GP/RG

SHC1.64

TXG4.06

Ticker research

View SHC research View TXG research

Metric	SHC Sotera Health Co	TXG 10X Genomics Inc
Market & Valuation
Market Cap	$5.15B	$10.24B
Enterprise Value	$7.03B	$9.74B
Price	$18.06	$80.65
P/E Ratio	31.83x	N/A
P/S Ratio	4.23x	16.60x
EV/Sales	5.78x	15.78x
EV/EBITDA	13.41x	0.00x
P/B Ratio	7.81x	14.76x
P/FCF Ratio	45.70x	84.32x
EV/FCF	62.36x	80.18x
PEG Ratio	3.19x	N/A
Forward P/E (NTM)	17.43x	N/A
Forward P/S (NTM)	3.98x	15.72x
Revenue & Growth
Revenue (TTM)	$1.22B	$617M
Revenue Growth (YoY)	8.1%	-4.3%
Forward Rev Growth	6.0%	9.4%
Profitability
Gross Margin (TTM)	55.0%	69.6%
Operating Margin (TTM)	32.6%	0.0%
EBITDA Margin (TTM)	43.1%	-7.8%
Net Margin (TTM)	13.4%	-12.2%
FCF Margin (TTM)	9.3%	19.7%
Net Income (TTM)	$163M	$-75M
FCF (TTM)	$113M	$121M
EPS (TTM)	$0.57	-$0.58
ROE (TTM)	26.8%	-933.0%
ROA (TTM)	5.0%	-730.0%
ROIC (TTM)	5.7%	-933.0%
Financial Health
Cash	$357M	$503M
Debt	$2.23B	$0
Net Cash/Debt	$-1.88B	$503M
Current Ratio (TTM)	2.80x	5.69x
Quick Ratio (TTM)	2.45x	5.09x
Debt/Equity (TTM)	3.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	2.01
52W Performance	12.9%	568.2%
YTD Performance	2.1%	385.3%
% from 52W High	-9.0%	-21.6%
% from 52W Low	38.0%	622.7%
Efficiency & Yields
Asset Turnover (TTM)	0.37x	0.60x
FCF Yield (TTM)	2.2%	1.2%
Earnings Yield (TTM)	3.2%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	17.4	15.4
EV/GP/RG	1.64	4.06
Ticker research	View SHC research	View TXG research

Valuation

P/E Ratio

SHC

31.83x

P/S Ratio

SHC

4.23x

TXG

16.60x

EV/FCF

SHC

62.36x

TXG

80.18x

Growth & revenue

Revenue Growth TTM

SHC

8.1%

TXG

-4.3%

Forward Revenue Growth

TXG

9.4%

SHC

6.0%

Profitability & performance

Gross Margin

TXG

69.6%

SHC

55.0%

ROE

SHC

26.8%

TXG

-933.0%

FCF Yield %

SHC

2.2%

TXG

1.2%

52-Week Performance

TXG

568.2%

SHC

12.9%

Detailed metrics comparison

SHC

Sotera Health Co

TXG

10X Genomics Inc

Market Cap

SHC$5.15B

TXG$10.24B

Enterprise Value

SHC$7.03B

TXG$9.74B

Price

SHC$18.06

TXG$80.65

P/E Ratio

SHC31.83x

TXGN/A

P/S Ratio

SHC4.23x

TXG16.60x

EV/Sales

SHC5.78x

TXG15.78x

EV/EBITDA

SHC13.41x

TXG0.00x

P/B Ratio

SHC7.81x

TXG14.76x

P/FCF Ratio

SHC45.70x

TXG84.32x

EV/FCF

SHC62.36x

TXG80.18x

PEG Ratio

SHC3.19x

TXGN/A

Forward P/E (NTM)

SHC17.43x

TXGN/A

Forward P/S (NTM)

SHC3.98x

TXG15.72x

Revenue (TTM)

SHC$1.22B

TXG$617M

Revenue Growth (YoY)

SHC8.1%

TXG-4.3%

Forward Rev Growth

SHC6.0%

TXG9.4%

Gross Margin (TTM)

SHC55.0%

TXG69.6%

Operating Margin (TTM)

SHC32.6%

TXG0.0%

EBITDA Margin (TTM)

SHC43.1%

TXG-7.8%

Net Margin (TTM)

SHC13.4%

TXG-12.2%

FCF Margin (TTM)

SHC9.3%

TXG19.7%

Net Income (TTM)

SHC$163M

TXG$-75M

FCF (TTM)

SHC$113M

TXG$121M

EPS (TTM)

SHC$0.57

TXG-$0.58

ROE (TTM)

SHC26.8%

TXG-933.0%

ROA (TTM)

SHC5.0%

TXG-730.0%

ROIC (TTM)

SHC5.7%

TXG-933.0%

Cash

SHC$357M

TXG$503M

Debt

SHC$2.23B

TXG$0

Net Cash/Debt

SHC$-1.88B

TXG$503M

Current Ratio (TTM)

SHC2.80x

TXG5.69x

Quick Ratio (TTM)

SHC2.45x

TXG5.09x

Debt/Equity (TTM)

SHC3.36x

TXG0.00x

Debt/Assets (TTM)

SHC0.0%

TXG0.0%

Interest Coverage (TTM)

SHCN/A

TXGN/A

Net Debt/EBITDA (TTM)

SHC0.00x

TXG0.00x

Beta

SHC1.93

TXG2.01

52W Performance

SHC12.9%

TXG568.2%

YTD Performance

SHC2.1%

TXG385.3%

% from 52W High

SHC-9.0%

TXG-21.6%

% from 52W Low

SHC38.0%

TXG622.7%

Asset Turnover (TTM)

SHC0.37x

TXG0.60x

FCF Yield (TTM)

SHC2.2%

TXG1.2%

Earnings Yield (TTM)

SHC3.2%

TXG-0.7%

Dividend Yield (TTM)

SHCN/A

TXGN/A

Rule of 40

SHC17.4

TXG15.4

EV/GP/RG

SHC1.64

TXG4.06

Ticker research

View SHC research View TXG research

Metric	SHC Sotera Health Co	TXG 10X Genomics Inc
Market & Valuation
Market Cap	$5.15B	$10.24B
Enterprise Value	$7.03B	$9.74B
Price	$18.06	$80.65
P/E Ratio	31.83x	N/A
P/S Ratio	4.23x	16.60x
EV/Sales	5.78x	15.78x
EV/EBITDA	13.41x	0.00x
P/B Ratio	7.81x	14.76x
P/FCF Ratio	45.70x	84.32x
EV/FCF	62.36x	80.18x
PEG Ratio	3.19x	N/A
Forward P/E (NTM)	17.43x	N/A
Forward P/S (NTM)	3.98x	15.72x
Revenue & Growth
Revenue (TTM)	$1.22B	$617M
Revenue Growth (YoY)	8.1%	-4.3%
Forward Rev Growth	6.0%	9.4%
Profitability
Gross Margin (TTM)	55.0%	69.6%
Operating Margin (TTM)	32.6%	0.0%
EBITDA Margin (TTM)	43.1%	-7.8%
Net Margin (TTM)	13.4%	-12.2%
FCF Margin (TTM)	9.3%	19.7%
Net Income (TTM)	$163M	$-75M
FCF (TTM)	$113M	$121M
EPS (TTM)	$0.57	-$0.58
ROE (TTM)	26.8%	-933.0%
ROA (TTM)	5.0%	-730.0%
ROIC (TTM)	5.7%	-933.0%
Financial Health
Cash	$357M	$503M
Debt	$2.23B	$0
Net Cash/Debt	$-1.88B	$503M
Current Ratio (TTM)	2.80x	5.69x
Quick Ratio (TTM)	2.45x	5.09x
Debt/Equity (TTM)	3.36x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.93	2.01
52W Performance	12.9%	568.2%
YTD Performance	2.1%	385.3%
% from 52W High	-9.0%	-21.6%
% from 52W Low	38.0%	622.7%
Efficiency & Yields
Asset Turnover (TTM)	0.37x	0.60x
FCF Yield (TTM)	2.2%	1.2%
Earnings Yield (TTM)	3.2%	-0.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	17.4	15.4
EV/GP/RG	1.64	4.06
Ticker research	View SHC research	View TXG research